On June 21, 2021, PMG Pharmascience Co., Ltd. (KOSDAQ:A073570) closed the transaction.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
2,955 KRW | -1.34% | -1.83% | -15.33% |
03-20 | JW (Cayman) Therapeutics Shrinks Loss in Fiscal 2023 | MT |
03-18 | JW Holdings Corporation Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Stocks mentioned in the article
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
128,800 KRW | -0.77% | -3.52% | 2.56B | ||
7,590 KRW | -1.30% | -5.24% | 2.93B | ||
5,040 KRW | +1.41% | -0.79% | 131M | ||
4,205 KRW | +2.31% | +2.94% | 276M | ||
1st Jan change | Capi. | |
---|---|---|
-15.33% | 158M | |
+18.71% | 44.35B | |
+19.44% | 15.08B | |
+19.49% | 14.37B | |
+57.58% | 13.06B | |
-0.05% | 6.79B | |
-10.85% | 6.75B | |
-8.87% | 5.73B | |
+12.55% | 5.64B | |
+4.00% | 4.66B |
- Stock Market
- Equities
- A096760 Stock
- News JW Holdings Corporation
- PMG Pharmascience Co., Ltd. announced that it has received KRW 15 billion in funding from Eugene Investment & Securities Co.,Ltd., JJ Assets Co., Ltd., Mirae Asset Securities Co., Ltd., JW Holdings Corporation, Kiwoom Securities Co., Ltd.